OTC Pharmaceuticals - Mozambique

  • Mozambique
  • In 2024, the revenue in the OTC Pharmaceuticals market in Mozambique amounts to US$56.87m.
  • It is projected to grow annually by 6.18% (CAGR 2024-2029).
  • The largest market within this market is Other OTC Pharmaceuticals, with a market volume of US$25.31m in 2024.
  • When compared globally, the in the United States generates the highest revenue, reaching US$41,240.00m in 2024.
  • In terms of per capita figures, in Mozambique generates US$1.63 in revenue per person in 2024.
  • Furthermore, it is estimated that 0.93% of the total revenue in the OTC Pharmaceuticals market in Mozambique will be generated through online sales by 2024.
  • Mozambique's OTC Pharmaceuticals market is experiencing a surge in demand for traditional herbal remedies.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Mozambique has been experiencing significant growth in recent years. Customer preferences in the OTC Pharmaceuticals market in Mozambique have been shifting towards self-medication and convenience. As consumers become more health-conscious and seek quick solutions for minor ailments, they are increasingly turning to over-the-counter medications. This trend is in line with the global market, where consumers are seeking more control over their healthcare and are opting for self-care options. The convenience factor is also driving the demand for OTC Pharmaceuticals in Mozambique, as consumers prefer to avoid the hassle of visiting a doctor for minor ailments that can be easily treated with OTC medications.One of the key trends in the OTC Pharmaceuticals market in Mozambique is the increasing availability and accessibility of OTC medications. As the healthcare infrastructure improves and more pharmacies and drugstores open across the country, consumers have easier access to a wide range of OTC medications. This trend is driven by the government's efforts to improve healthcare access and the growing presence of multinational pharmaceutical companies in the country. Additionally, the rise of e-commerce platforms has further expanded the availability of OTC medications, allowing consumers to purchase them online and have them delivered to their doorstep.Another trend in the OTC Pharmaceuticals market in Mozambique is the growing demand for natural and herbal remedies. As consumers become more conscious of the potential side effects of synthetic medications, they are turning to natural alternatives. This trend is in line with the global market, where there is a growing demand for natural and organic products across various industries. As a result, pharmaceutical companies are introducing more natural and herbal OTC medications to cater to this demand.Local special circumstances in Mozambique, such as the high prevalence of malaria and other tropical diseases, have also contributed to the growth of the OTC Pharmaceuticals market. Mozambique has a high burden of infectious diseases, and OTC medications for the prevention and treatment of these diseases are in high demand. Additionally, the country has a large rural population with limited access to healthcare facilities, making OTC medications a crucial part of their healthcare options.Underlying macroeconomic factors, such as population growth, urbanization, and increasing disposable income, are driving the growth of the OTC Pharmaceuticals market in Mozambique. With a growing population and increasing urbanization, the demand for healthcare products and services is expected to rise. Additionally, as disposable income levels increase, consumers are more willing to spend on OTC medications for their healthcare needs.In conclusion, the OTC Pharmaceuticals market in Mozambique is experiencing significant growth due to shifting customer preferences towards self-medication and convenience, increasing availability and accessibility of OTC medications, growing demand for natural and herbal remedies, local special circumstances, and underlying macroeconomic factors.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)